London, Canada

Catherine E Hildebrand

This inventor holds 1 USPTO granted patent. Top assignee: Bioniche, Inc.. Active years: 2000.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Catherine E Hildebrand: Innovator in Parasitic Disease Treatment

Introduction

Catherine E Hildebrand is a notable inventor based in London, Canada. She has made significant contributions to the field of veterinary medicine, particularly in the treatment of parasitic diseases in animals. Her innovative approach has the potential to improve the health and well-being of countless animals affected by these conditions.

Latest Patents

Catherine holds a patent for a method aimed at treating or eliminating a protozoal or parasitic disease in animals. The patent describes a process in which a sufficient amount of a bacterial cell wall extract is administered to the affected animal. The extract is preferably derived from mycobacterial or corynebacterium cell walls, with the most effective being a Mycobacterium phlei cell wall extract. This innovative method represents a significant advancement in veterinary treatment options.

Career Highlights

Catherine has dedicated her career to research and development in the field of veterinary medicine. Her work at Bioniche, Inc. has allowed her to focus on innovative solutions for treating parasitic diseases. With her expertise and commitment, she has become a respected figure in her field.

Collaborations

Catherine has collaborated with esteemed colleagues, including Dragan R Rogan and Stanley J Alkemade. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in veterinary medicine.

Conclusion

Catherine E Hildebrand's contributions to the treatment of parasitic diseases in animals highlight her innovative spirit and dedication to improving animal health. Her patent and ongoing work at Bioniche, Inc. exemplify the impact of her research in the veterinary field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…